Metabolic and proteomic signatures differentiate inflammatory phenotypes from cancer and predict treatment response in patient sera is a research paper published in Bioengineering & Translational Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01EB029756‐01A1
National Institutes of Health
Grant: 5UH2CA271230
National Institutes of Health
Grant: 4UH3CA271230
Congressionally Directed Medical Research Programs
Grant: W81XWH‐20‐1‐0620
Congressionally Directed Medical Research Programs
Grant: HT9425‐23‐1‐0840
Congressionally Directed Medical Research Programs
Grant: W81XWH‐18‐1‐0148
National Cancer Institute
Grant: P30 CA006927
Iowa State University
Grant: Jean H. Steffenson Professorship
NCI NIH HHS
Grant: UH3 CA271230
NCI NIH HHS
Grant: UH2 CA271230
National Institutes of Health
Grant: 5P30CA006927-49
Transgenic Mouse
National Institutes of Health
Grant: 5UH2CA271230-02
Validation of blood-based predictive biomarkers of therapeutic response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
National Institutes of Health
Grant: 1R01EB029756-01A1
Developing Multimodal Multiplexed ImmunoPET-Raman Probes to Guide Immunotherapies
FWCI
1.60
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords